FOR IMMEDIATE RELEASE November 19, 20007 CASPIAN RELEASES MICROCHIP CANCER REPORT Sets record straight after misleading claims by HomeAgain and VeriChip implant manufacturers A new paper titled "Microchip-Induced Tumors in Laboratory Rodents and Dogs: A Review of the Literature 1990-2006" has been released today by CASPIAN. The full, 48-page paper provides a definitive review of the academic literature showing a causal link between implanted radio-frequency (RFID) microchip transponders and cancer in laboratory rodents and dogs. In addition, a brief, four-page synopsis of the full report is being made available. Eleven articles previously published in toxicology and pathology journals are evaluated in the report. In six of the articles, between 0.8% and 10.2% of laboratory mice and rats developed malignant tumors around or adjacent to the microchips, and several researchers suggested the actual tumor rate may have been higher. Two additional articles reported microchip-related cancer in dogs. In almost all cases, the malignant tumors, typically sarcomas, arose at the site of the implants and grew to surround and fully encase the devices. In several cases the tumors also metastasized or spread to other parts of the animals. Public revelation of a casual link between microchipping and cancer in animals has prompted widespread public concern over the safety of implantable microchips. The story was first broken to the public in September through an article written by Associated Press Reporter Todd Lewan. Prior to the AP story, the journal articles were completely unknown outside of small academic circles.

"The AP did a superb job informing the public of the existence of these journal articles," said Dr. Katherine Albrecht, a leading privacy expert and long-time VeriChip opponent who authored the new paper."Unfortunately," Dr. Albrecht added, "a lot of misinformation about the cancer research has circulated since Mr. Lewan’s article was published. I wrote the report to set the record straight." The animal-microchip study findings were so compelling that one of Mr. Lewan’s sources, Dr. Robert Benezra, head of the Cancer Biology Genetics Program at the Memorial Sloan-Kettering Cancer Center in New York, was quoted as saying, "There’s no way in the world, having read this information, that I would have one of those chips implanted in my skin, or in one of my family members." Nevertheless, representatives of the chipping industry have made inaccurate public statements about the research findings in an effort to confuse the public. Scott Silverman, CEO of the VeriChip Corporation which makes the controversial VeriChip human implant, recently provided inaccurate information to Time Magazine. Mr. Silverman is quoted as saying that none of the tumors found in mice in a 2006 French study were malignant. In fact, not only were the tumors malignant sarcomas, but most of the afflicted animals died prematurely as a result of the microchip-associated tumors. In addition, Destron Fearing, makers of the HomeAgain pet implant, dismissed a finding of  fibrosarcoma–a highly lethal cancer–as ‘benign’ in a recent report. A fibrosarcoma is a type of sarcoma, a malignant tumor of soft tissue that connects, supports or surrounds other structures and organs of the body. Dr. Timothy Jennings, an expert on implant-induced cancers in humans, said he was "not aware of any nosology incorporating an entity of ‘benign fibrosarcoma’" and agreed that "any tumor classified as sarcoma should be viewed as malignant." "Either VeriChip and the makers of HomeAgain actually don’t understand the difference between a benign fibroma and a malignant fibrosarcoma," noted Dr. Albrecht, "or they’re deliberately lying to the public. Either way, it’s clear they can’t be trusted. We hope our new report will set the record straight." The report includes a one- to three-page writeup on each of the original studies. In addition to a detailed review of the academic literature, the report contains recommendations for patients, pet owners, veterinarians, and policy makers, including the following: (1) Further microchipping of humans should be immediately discontinued; (2) Implanted patients should be informed in writing of the research findings and offered a procedure for microchip removal; and (3) Policy makers should reverse all animal microchipping mandates. As part of its public awareness campaign, CASPIAN will be issuing copies of the new report to leading policy and decision makers. The full 48-page report and four-page synopsis are also immediately available for public download at http://www.antichips.com/cancer/ For more great content, information and stories like this, please Join Us, Monday LIVE @ 11:00 MST for: Your Online Security Authority   Bill Wardell

Written by: OSAblogger / Bill Wardell - Please Read Our Latest OSA eZine Edition

Other Places You Can Find Me…

Digg - LinkedIn - OSA Community - Facebook - StumbleUpon - MyBlogLog

If you're a concerned parent, you may want to subscribe to the: OSA~RSS while your here, please JOIN our: OSA Forum... also Follow Me On Twitter Thanks for visiting!

OSA Technorati Tags: Katherine Albrecht, Memorial Sloan-Kettering Cancer Center, Online Security Authority, tumor, Tumors, VeriChip Corporation

OSA Related Posts

• RFID-tagged cards for border-crossing purposes. Attention, all OSA friends, Katherine Albrecht, Ed.D., is about to leave for Phoenix, where she and other advocates will be briefing the Arizona state legislature on privacy issues associated with new remotely-readable, spychipped "enhanced" driver's licenses. If you are in the area, you are invited to join us on Thursday......
• CASPIAN - Group's Latest Report Sets Record Straight on Chip Implants, Cancer, and more! CASPIAN RELEASES NEW EVIDENCE OF VERICHIP LIES AND DECEPTION To all the friends and visitors of OSA, the Opponents of the VeriChip implant are launching a new offensive against the controversial human microchip this week, amid reports that VeriChip plans to put its chipping division on the auction block. A......
• The A.M.A. Gets Under Your Skin By Barnaby J. Feder | June 27, 2007,  7:51 pm  On Monday, the delegates to the annual meeting in Chicago of the American Medical Association  endorsed what could only be described as a cautious committee report on the role of implanted radio identification tags in patient care. The three recommendations were......
• WoW Lead - Participating the General of Warcraft for the Novice If you are new to the Public of Warcraft or the gaming scene in standard, then you could do with a little info about this MMORPG phenomenon. Maybe, you are reading this lead because of your girlfriend dumped you for not playing WoW; then you experience how great a phenomenon......
• Is your local Public Library on MySpace? Keeping our Children Safe do You Need Help? can you Use Ours? In doing a little research on teens and MySpace, there is becoming an overwhelmingly high number of search engine results for public libraries who have decided to make MySpace pages to attract the teenagers.  Depending on your personal......

OSA Related Websites

• Combination Therapy Targets Pancreatic Cancer Stem Cells Image via Wikipedia A new drug combination tested in mice may target the cells responsible for driving some pancreatic tumors. The combination of gemcitabine and the experimental drug tigatuzumab eliminated populations of cancer stem cells and reduced tumor growth in a mouse model of pancreatic cancer, researchers from the......
• Cancer Cure? Asparagus! I received an email worth reading. It is about asparagus and its role in defeating cancer. I guess this would be an interesting post since we always try natural and less expensive ways to cure ourselves when we are sick. We want natural because it is inherent in us to......
• POTENTIAL NEW “TWIST” IN BREAST CANCER DETECTION Image via Wikipedia December 4, 2009- Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called “Twist” may be the proverbial red flag that can accurately distinguish stem cells that drive aggressive, metastatic breast cancer......
• Diabetes Medication May Get New Life as Cancer Treatment The drug metformin, a mainstay of diabetes care for 15 years, may have a new life as a cancer treatment, researchers said. In a study in mice, low doses of the drug, combined with a widely used chemotherapy called doxorubicin, shrank breast-cancer tumors and prevented their recurrence more effectively than......
• What is the Best Credit Score? The calculations that are used to arrive at your credit score are actually based on a lot of different statistical data, and they are based on objective evaluations. You receive points based on a number of different unique credit factors. Then, creditors are going to take all of this information......